ALNYLAM PHARMACEUTICALS INC(NASDAQ:ALNY) stock News

ALNY Latest News, Press Relases and Analysis

All

Press Releases

5 days ago - By: Bloomberg - Mentions: PFE BBIO

BridgeBio Says Pfizer, Alnylam Aren’t Playing Fair in Blockbuster Race

7 days ago - By: Alnylam Pharmaceuticals, Inc.

Alnylam Announces Pricing of Upsized Offering of $575 Million Convertible Senior Notes

8 days ago - By: Alnylam Pharmaceuticals, Inc.

Alnylam Announces Proposed Offering of $500 Million Convertible Senior Notes

8 days ago - By: Benzinga

Here's How Much $1000 Invested In Alnylam Pharmaceuticals 10 Years Ago Would Be Worth Today

14 days ago - By: Benzinga

$1000 Invested In Alnylam Pharmaceuticals 15 Years Ago Would Be Worth This Much Today

8 days ago - By: Zacks Investment Research - Mentions: PFE BBIO

Can ALNY's Key Partnerships With Pharma Giants Drive Long-Term Growth?

12 days ago - By: Zacks Investment Research

Are Options Traders Betting on a Big Move in Alnylam Pharmaceuticals Stock?

14 days ago - By: Yahoo Finance

Should You Add Alnylam Pharmaceuticals (ALNY) to Your Portfolio?

15 days ago - By: Zacks Investment Research - Mentions: CRMD KNSA

ALNY/RHHBY's Zilebesiran to Enter Phase III After Third Phase II Win

16 days ago - By: Alnylam Pharmaceuticals, Inc.

New Data From Landmark HELIOS-B Phase 3 Study Presented at ESC Congress 2025 Demonstrate Vutrisiran’s Long-Term Cardiovascular Benefit in ATTR-CM

17 days ago - By: Alnylam Pharmaceuticals, Inc.

Alnylam to Advance Zilebesiran into Global Phase 3 Cardiovascular Outcomes Trial

19 days ago - By: Zacks Investment Research - Mentions: PFE BBIO

Can Alnylam Rely on Amvuttra to Sustain Its Rapid Sales Momentum?

20 days ago - By: Alnylam Pharmaceuticals, Inc.

Alnylam to Webcast Presentations at Upcoming September Investor Conferences

a month ago - By: Yahoo Finance - Mentions: UNH CNC OSCR ELV ...

Solar, biotech, and health insurance stocks are rising on Friday: here's why

a month ago - By: Yahoo Finance - Mentions: TSLA

Profits May Be Just Around the Corner for This Strong-Buy Pharma Stock

a month ago - By: Alnylam Pharmaceuticals, Inc.

Alnylam to Present Progress in Transforming the Treatment of Cardiovascular Disease with RNAi Therapeutics at European Society of Cardiology Congress 2025

a month ago - By: Alnylam Pharmaceuticals, Inc.

Alnylam to Webcast Presentation at Canaccord Genuity 45th Annual Growth Conference

a month ago - By: Zacks Investment Research

Earnings Estimates Rising for Alnylam (ALNY): Will It Gain?

a month ago - By: Zacks Investment Research - Mentions: ADCT

Are Medical Stocks Lagging ADC Therapeutics (ADCT) This Year?

2 months ago - By: Zacks Investment Research - Mentions: REGN NVS

ALNY Q2 Earnings Top Estimates on Higher Amvuttra Revenues, Stock Up

2 months ago - By: Yahoo Finance - Mentions: PFE

Alnylam reaches new highs on strong sales of closely watched rare disease drug

2 months ago - By: Alnylam Pharmaceuticals, Inc.

Alnylam Pharmaceuticals Reports Second Quarter 2025 Financial Results and Highlights Recent Period Progress